Announcement on Voluntary Disclosure on the Acceptance of New Drug Application for BGM0504 Injection for Weight Loss Indication

About this update from Brightgene Bio-medical Technology Co. Ltd. Class A

Announcement on Voluntary Disclosure on the Acceptance of New Drug Application for BGM0504 Injection for Weight Loss Indication The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Brightgene Bio-medical Technology Co. Ltd. Class A